iOcuCoat is a premium ophthalmic viscoelastic solution designed for intraocular use during surgical procedures such as cataract extraction and intraocular lens implantation. This advanced formulation combines Sodium Hyaluronate (3% w/v) and Sodium Chondroitin Sulfate (4% w/v) to provide exceptional lubrication and maintain the anterior chamber's structural integrity. Sodium Hyaluronate enhances tissue protection and reduces friction, while Sodium Chondroitin Sulfate offers superior viscoelastic properties to cushion delicate ocular tissues. Together, they ensure optimal visibility for surgeons, promote precision, and minimize trauma to the corneal endothelium. Packaged in a sterile 1ml syringe, iOcuCoat is ready to use, ensuring convenience and efficiency in surgical settings. This product is trusted by ophthalmic professionals worldwide for its consistency and performance, delivering high patient outcomes and facilitating smooth surgical experiences.
Mumbai
iOcuCoat+ is a premium ophthalmic viscoelastic solution designed for intraocular use during surgical procedures such as cataract extraction and intraocular lens implantation. This advanced formulation combines Sodium Hyaluronate (2% w/v) and Sodium Chondroitin Sulfate (2% w/v) to provide exceptional lubrication and maintain the anterior chamber's structural integrity. Sodium Hyaluronate enhances tissue protection and reduces friction, while Sodium Chondroitin Sulfate offers superior viscoelastic properties to cushion delicate ocular tissues. Together, they ensure optimal visibility for surgeons, promote precision, and minimize trauma to the corneal endothelium. Packaged in a sterile 1ml syringe, iOcuCoat+ is ready to use, ensuring convenience and efficiency in surgical settings. This product is trusted by ophthalmic professionals worldwide for its consistency and performance, delivering high patient outcomes and facilitating smooth surgical experiences.
Mumbai
iOcuCoat CS is a premium ophthalmic viscoelastic solution designed for intraocular use during surgical procedures such as cataract extraction and intraocular lens implantation. This advanced formulation combines Sodium Hyaluronate (1.7% w/v) and Sodium Chondroitin Sulfate (4% w/v) to provide exceptional lubrication and maintain the anterior chamber's structural integrity. Sodium Hyaluronate enhances tissue protection and reduces friction, while Sodium Chondroitin Sulfate offers superior viscoelastic properties to cushion delicate ocular tissues. Together, they ensure optimal visibility for surgeons, promote precision, and minimize trauma to the corneal endothelium. Packaged in a sterile 1ml syringe, iOcuCoat CS is ready to use, ensuring convenience and efficiency in surgical settings. This product is trusted by ophthalmic professionals worldwide for its consistency and performance, delivering high patient outcomes and facilitating smooth surgical experiences.
Mumbai